Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis

Treatment options for patients newly diagnosed with multiple sclerosis (MS) are expanding with the continuous development and approval of new disease-modifying therapies (DMTs). The optimal initial treatment strategy, however, remains unclear. The 2 main treatment paradigms currently employed are the escalation (ESC) approach and the early highly effective treatment (EHT) approach. The ESC approach consists of starting a lower- or moderate-efficacy DMT, which offers a potentially safer approach, while the EHT approach favors higher-efficacy treatment early in the disease course, despite a potential increase in risk. Randomized clinical trials aiming to directly compare these approaches in newly diagnosed MS patients are currently underway.

Source: Neurologic Clinics - August 21, 2023 Category: Neurology Authors: Nicole Bou Rjeily, Ellen M. Mowry, Daniel Ontaneda, Alise K. Carlson Source Type: research